ROIV - Roivant Sciences Ltd.

29.29
0.210   0.717%

Share volume: 2,947,667
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$29.08
0.21
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
42%
Profitability 35%
Dept financing 23%
Liquidity 58%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.81%
1 Month
4.87%
3 Months
27.51%
6 Months
63.08%
1 Year
181.09%
2 Year
176.32%
Key data
Stock price
$29.29
P/E Ratio 
0.00
DAY RANGE
$28.67 - $29.36
EPS 
-$0.61
52 WEEK RANGE
$10.58 - $30.33
52 WEEK CHANGE
$172.72
MARKET CAP 
15.092 B
YIELD 
N/A
SHARES OUTSTANDING 
715.701 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.76
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,397,207
AVERAGE 30 VOLUME 
$4,509,494
Company detail
CEO: Matthew Gline
Region: US
Website: roivant.com
Employees: 860
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom.

Recent news